Keyword: Andrew Witty

News

GSK to Waive Patents in Poor Countries

01.04.2016 - Glaxo SmithKline has announced it will waive patent protection for new medicines in the world’s poorest countries, such as Afghanistan, Rwanda and Cambodia, allowing cheaper...

News

GSK’s Witty Names Retirement Date

18.03.2016 - It’s official. Andrew Witty, CEO of Britain’s largest drugmaker, Glaxo SmithKline (GSK), has announced he will retire in March 2017 after nearly a decade at the helm. In a...

News

AstraZeneca Shareholders Target CEO Pay

16.03.2016 - AstraZeneca shareholders are said to be questioning the £8.4 million pay package awarded to CEO executive Pascal Soriot last year after he successfully deflected a hostile bid from...

News

Search to Replace GSK Chief Said Underway

01.03.2016 - British drugmaker GlaxoSmithKline is said to have launched a search for a new CEO to replace Andrew Witty, who is now widely expected to step down at the latest by the end of 2017...

News

GSK Chief Says UK “Better in EU”

05.02.2016 - Glaxo SmithKline CEO Andrew Witty has become the first pharmaceutical or chemical company executive to come out in favor of the UK remaining in the EU, although business leaders in...

News

Drug Firms Urge Governments to Fight Superbugs

26.01.2016 - More than 80 international drug and biotechnology companies have urged governments to work with them to combat the emergence of drug-resistant superbugs, according to a report by...

News

GSK Outlines Pipeline for Next 10 Years

06.11.2015 - GlaxoSmithKline (GSK) is expecting to file 20 new drugs by 2020, with another 20 to follow in the following five years. In a presentation to investors in New York, CEO Andrew Witty...

Markets & Companies

Pharma Players Mostly Lift 2015 Guidance

07.10.2015 - After a challenging second quarter and first half 2015 – once again marked by foreign exchange turbulence and the impact of acquisitions and divestments – the international...